Eclectic Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$301K Buy
+2,068
New +$286K 0.03% 128
2024
Q4
– Sell
-2,966
Closed -$337K – 120
2024
Q3
$337K Buy
2,966
+67
+2% +$7.96K 0.13% 82
2024
Q2
$359K Buy
2,899
+40
+1% +$5.15K 0.16% 68
2024
Q1
$377K Sell
2,859
-128
-4% -$15.8K 0.17% 65
2023
Q4
$326K Buy
+2,987
New +$310K 0.16% 63
2023
Q3
– Sell
-2,017
Closed -$233K – 85
2023
Q2
$233K Sell
2,017
-281
-12% -$31.9K 0.11% 73
2023
Q1
$244K Sell
2,298
-11
-0.5% -$1.19K 0.13% 71
2022
Q4
$256K Buy
+2,309
New +$236K 0.12% 67
2022
Q3
– Sell
-2,209
Closed -$201K – 66
2022
Q2
$201K Buy
+2,209
New +$196K 0.14% 66

Other funds holding MRK

Eclectic Associates's MRK Position: Q3 2026 in Review

Eclectic Associates opened a new position in Merck (MRK) in Q3 2026: 2,068 shares worth $301K. The stake represents 0.03% of the portfolio and ranks #128 among its holdings. This is a return to the name: Eclectic Associates previously reported a position in MRK as recently as Q3 2024.

Eclectic Associates first reported a position in MRK in Q2 2022 and has held it in 9 quarters since. The position peaked at $377K in Q1 2024. 2,647 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Eclectic Associates held 2,068 shares of Merck worth $301K as of Q3 2026.
  • Merck was a new Eclectic Associates position in Q3 2026.
  • Merck made up 0.03% of Eclectic Associates's portfolio in Q3 2026, its #128 holding.
  • Eclectic Associates first reported a position in Merck in Q2 2022 and has held it in 9 quarters since.
  • Eclectic Associates's Merck position peaked at $377K in Q1 2024.
  • 2,647 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Eclectic Associates's 13F filing for Q3 2026, filed 9 Oct 2026.